TXG
10x Genomics, Inc.
10x Genomics, Inc. (TXG) has 11 SEC Form 4 filings (16 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Jun 24, 2026.
The most active filer is Chief Executive Officer Saxonov Serge with 3 filings. Insiders have net sold $2.6M over the trailing 6 months.
- Industry:Medical - Healthcare Information Services
- CEO:Serge Saxonov
- Employees:1,306
- HQ:Pleasanton, CA, US
- IPO:2019-09-12
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.6M
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Market Cap
$5.7B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Chief Executive Officer | Sale | 30,000 | $1.0M | Jun 24 | SEC ↗ | |
| Director | Sale | 5,723 | $187K | Jun 18 | SEC ↗ | |
Saxonov SergeFirst filing | Chief Executive Officer | Sale | 18,175 | $444K | May 27 | SEC ↗ |
Saxonov SergeFirst filing | Chief Executive Officer | Sale | 10,718 | $265K | May 27 | SEC ↗ |
Hindson Benjamin J.First filing | See Remarks | Sale | 11,595 | $283K | May 27 | SEC ↗ |
Taich AdamFirst filing | Chief Financial Officer | Sale | 15,098 | $369K | May 27 | SEC ↗ |
Related companies
10x Genomics, Inc. is in the Healthcare sector.